LACTOLOGY FOUNDATION

Substance identification

Magnesium peroxide is an inorganic magnesium salt and oxygen‑releasing compound used as an antacid in the ATC subgroup A02AA “Magnesium compounds” with the specific code A02AA03.
It is a white to off‑white, odorless, fine powder, structurally related to calcium peroxide and capable of controlled oxygen release in aqueous media.

Pharmacotherapeutic group (ATC)

Within the Anatomical Therapeutic Chemical (ATC) system, magnesium peroxide belongs to the “Drugs for acid related disorders” group (A02), antacids (A02A), magnesium compounds (A02AA), with specific code A02AA03.
It is also listed under A06AD03 among magnesium‑containing laxatives in the domain of drugs affecting the alimentary tract and metabolism.

Mechanism of action

As an antacid, magnesium peroxide acts primarily through neutralization of gastric hydrochloric acid after partial conversion to magnesium hydroxide, producing magnesium salts and water and thereby increasing intragastric pH.
The oxygen‑releasing properties of magnesium peroxide are considered secondary in the gastrointestinal indication and are mainly exploited in environmental and agricultural applications rather than in contemporary clinical pharmacology.

Indications and clinical use

Historically and according to ATC classification, magnesium peroxide is indicated as an antacid for symptomatic relief of acid‑related upper gastrointestinal complaints such as heartburn, acid indigestion and dyspepsia, similarly to other magnesium antacids.
In some classifications it is also grouped with magnesium laxatives, where higher osmotic doses can promote bowel evacuation in functional constipation, analogous to magnesium hydroxide and other magnesium salts.

Dosage and administration

Specific modern dose recommendations for magnesium peroxide as a stand‑alone medicinal product are seldom provided, and dosing is generally extrapolated from other oral magnesium antacids and laxatives where the elemental magnesium content and renal function guide the regimen.
In practice, administration is usually oral, divided into one or more doses per day, taken with food or water and limited in duration unless otherwise advised, in order to minimize cumulative magnesium load and gastrointestinal adverse effects.

General toxicology and adverse effects

Magnesium peroxide is an irritant: contact with skin or eyes can cause redness, itching, swelling and burning, while inhalation of dust may irritate the respiratory tract, provoking cough, throat irritation, chest tightness and, with prolonged exposure, potential lung damage.
Following ingestion, typical dose‑related adverse reactions include bloating, belching, abdominal pain, nausea, vomiting, diarrhea and general gastrointestinal irritation, consistent with the well‑known laxative and osmotic properties of magnesium salts.

Contraindications and precautions

As with other magnesium antacids and laxatives, magnesium peroxide is contraindicated in patients with hypersensitivity to magnesium compounds and must be used cautiously in individuals with significant renal impairment because of the risk of magnesium accumulation and hypermagnesemia.
Caution is also recommended in patients with neuromuscular disorders (such as myasthenia gravis) or severe gastrointestinal pathology (e.g. ulcerative colitis, diverticulitis, intestinal obstruction, colostomy/ileostomy), in whom altered motility or permeability may modify systemic exposure.

Toxicological risk during lactation (lactological assessment)

There are no specific clinical studies of magnesium peroxide in breastfeeding women; however, toxicological assessment can rely on data from closely related magnesium salts such as magnesium hydroxide and magnesium oxide, which share the same cation, route of administration and local antacid/laxative action.
For magnesium hydroxide and magnesium oxide, available evidence indicates minimal transfer into breast milk, poor oral absorption of magnesium from the infant gut and no reported adverse effects in breastfed infants, leading authoritative sources to consider these magnesium antacids compatible with breastfeeding without the need for special precautions.

Mechanistic basis of lactation safety

From a toxicokinetic standpoint, orally administered magnesium peroxide undergoes partial hydrolysis in the gastrointestinal tract to magnesium hydroxide and other poorly absorbable magnesium species, with limited systemic absorption in individuals with normal renal function.
Only very small increments in maternal serum and milk magnesium concentrations are expected at therapeutic antacid doses, and because oral bioavailability of magnesium in the breastfed infant is low, clinically relevant systemic exposure of the infant is unlikely under normal conditions.

Defined toxicological risk categorization during breastfeeding

Based on the structural analogy with other magnesium antacids, their established safety profiles in breastfeeding, and the pharmacokinetic characteristics of oral magnesium salts, magnesium peroxide can be classified as presenting a low toxicological risk during lactation when used at standard short‑term antacid doses in healthy mothers with preserved renal function.
Heightened risk may arise in situations of maternal renal insufficiency, chronic high‑dose magnesium exposure or in premature or medically fragile infants, where closer clinical monitoring and, if necessary, selection of a non‑magnesium antacid alternative are prudent toxicological‑lactological precautions.

Practical recommendations for breastfeeding women

For breastfeeding women without renal disease who require short‑term antacid therapy, magnesium‑based products, by analogy with magnesium hydroxide and magnesium oxide, are generally acceptable, and magnesium peroxide can be used with attention to the lowest effective dose and limited duration.
Clinicians should advise mothers to avoid excessive or prolonged self‑medication with magnesium peroxide, to report persistent diarrhea, and to seek medical evaluation if the breastfed infant develops unexplained hypotonia, poor feeding or reduced deep tendon reflexes suggestive of potential magnesium excess.

Environmental and occupational considerations

Outside medicine, magnesium peroxide is widely used as a stable oxygen‑releasing agent in environmental remediation (e.g. groundwater decontamination) and in agricultural applications, which may create occupational exposure through inhalation or dermal contact.
These uses underline the need for appropriate workplace protective measures (dust control, eye and skin protection) to reduce irritant effects, but they do not materially change the very low systemic doses associated with therapeutic oral antacid use during breastfeeding.